Clinical Trials

Showing trials with last updates posted in 2026.

NCT06710210 | RECRUITING | NA
150 participants

Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2026-04-01
Completion:
2028-04-01
Conditions
  • Coronary Artery Disease
  • Diffuse Coronary Artery Disease
  • Percutaneous Coronary Intervention (PCI)
Interventions
  • DEVICE
No Results Yet
NCT06697717 | COMPLETED | NA
15 participants

End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance Tomography-guided PEEP Titration Methods in Patients With Intra-abdominal Hypertension Combined With Acute Respiratory Distress Syndrome: a Randomized Crossover Controlled Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2024-12-31
Completion:
2026-02-20
Conditions
  • Intra-abdominal Hypertension
  • Acute Respiratory Distress Syndrome (ARDS)
Interventions
  • OTHER
No Results Yet
NCT06673017 | RECRUITING | PHASE1
26 participants

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2025-04-14
Completion:
2026-12-31
Conditions
  • Pancreatic Ductal Adenocarcinoma
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Adenocarcinoma
  • Pancreatic Cancer
Interventions
  • DRUG
No Results Yet
NCT06671912 | SUSPENDED | PHASE3
1556 participants

Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2025-02-19
Completion:
2030-11-30
Conditions
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • Anatomic Stage 1 Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Estrogen Receptor-Positive Breast Carcinoma
  • HER2-Negative Breast Carcinoma
  • Breast Ductal Carcinoma In Situ
  • Breast Lobular Carcinoma In Situ
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT06661720 | RECRUITING | PHASE3
1040 participants

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2025-03-14
Completion:
2037-11-30
Conditions
  • Clear Cell Renal Cell Carcinoma
  • Renal Cell Carcinoma (RCC)
  • Stage II Renal Pelvis Cancer AJCC v8
  • Stage III Renal Pelvis Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
NCT06596746 | RECRUITING
600 participants

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-02
Start Date:
2024-09-09
Completion:
2034-09-09
Conditions
  • Neurodegenerative Diseases
  • Parkinson Disease
  • Synucleinopathies
  • Lewy Body Disease
  • Multiple System Atrophy
  • Tauopathies
  • Alzheimer Disease
  • Corticobasal Degeneration
  • Supranuclear Palsy, Progressive
  • Atypical Parkinsonism
  • TDP-43 Proteinopathies
  • Amyotrophic Lateral Sclerosis
  • Frontotemporal Lobar Degeneration
  • Movement Disorders
  • Cognitive Impairment
  • Dementia
  • Iron Overload
  • Neurodegeneration With Brain Iron Accumulation (NBIA)
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page